Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Genetics and clinical response to warfarin and edoxaban in patients with venous thromboembolism.
Journal: Heart (British Cardiac Society)
Published: November 10, 2016
An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure.
Journal: The pharmacogenomics journal
Published: February 24, 2016
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.
Journal: Journal of thrombosis and thrombolysis
Published: November 18, 2015
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Journal: Lancet (London, England)
Published: March 15, 2015
The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease.
Journal: Thrombosis and haemostasis
Published: October 31, 2013
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.
Journal: Thrombosis and haemostasis
Published: September 17, 2013
Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial.
Journal: Thrombosis and haemostasis
Published: September 09, 2013
Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin.
Journal: Diabetes research and clinical practice
Published: August 29, 2013
Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.
Journal: Thrombosis and haemostasis
Published: March 29, 2013
The effects of colesevelam HCl on the single-dose pharmacokinetics of glimepiride, extended-release glipizide, and olmesartan medoxomil.
Journal: Journal of clinical pharmacology
Published: March 27, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026